ABI Buys Agencourt Personal Genomics from Beckman For $120M; Still Evaluating Other Sequencing Techs | GenomeWeb

Taking another step in its evolving strategy to gain a foothold in the next-generation DNA sequencing market, Applied Biosystems has inked a deal to acquire Agencourt Personal Genomics for approximately $120 million in cash.

The acquisition provides ABI with a relatively advanced technology in the emerging market for alternative DNA sequencing instruments, and the firm said it expects to place initial systems with early-access customers in 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.